ABBV

ABBV Operating Income Growth

72.13%TTM

Period ending:

ABBV TTM Operating Income YoY %%
ABBV TTM Operating Income YoY %140.25%-59.07%
2012-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ABBV operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 55 observations from Dec 31, 2012 to Jun 30, 2026.

AbbVie Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
72.128%
72.1704%
78.8333%
-34.5898%
-10.6258%
-21.2325%
-28.3766%
-8.2448%
-29.4145%
-20.9117%
-29.5855%
-14.8397%
-0.0345%
-12.7846%
1.0768%
6.541%
11.8313%
56.2674%
57.74%
43.5501%
42.3133%
-12.6179%
-12.4779%
75.6149%
53.3109%
109.1834%
103.3997%
-37.9733%
-29.7941%
-35.4422%
-33.2113%
4.9106%
3.7291%
5.6764%
1.8436%
10.7452%
12.9863%
17.0399%
24.5058%
82.4516%
112.1205%
116.9202%
120.9616%
-6.5659%
-29.2446%
-34.3783%
-39.7775%
-9.8975%
-6.5247%
-7.0621%
-2.6284%
10.6989%
61.1211%
62.7824%
60.6551%

Compare operating income growth

All ABBV financial metrics · ABBV stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.